Novel technology paves the way for use of the company's industry-leading point-of-care electroencephalography (EEG) system to address long unmet need in delirium monitoring SUNNYVALE, Calif., Dec. 09, ...
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. CeriBell focuses on improving detection and management of ...
CeriBell (NASDAQ:CBLL) executives said the company's first-quarter results reflected continued momentum in both new account additions and increased usage among existing hospital customers, while ...
Ceribell's breakthrough technology can now be deployed in federal healthcare facilities, including U.S. Department of Veterans Affairs hospitals, helping clinicians deliver faster diagnosis and ...
Hosted on MSN
CeriBell Q1 Earnings Call Highlights
CeriBell (NASDAQ:CBLL) reported first-quarter revenue growth of 29% and raised its full-year outlook, as management cited higher usage of its seizure monitoring system and the company's strongest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results